GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

HONG KONG, Jan. 5, 2026 /PRNewswire/ — GenEditBio Limited ("GenEditBio"), a clinical-stage…

GMA Capital Partners Joins Responsible Investment Association Australasia

SINGAPORE, Jan. 5, 2026 /PRNewswire/ — GMA Capital Partners has been approved…

KT&G's Indonesian Factory Acquires 'ISO 45001' Certification

– Establishes overseas manufacturing system meeting global health & safety standards following…

C&R Research, the 'K-Clinical Hub', Strengthens Partnerships in Indonesia

Accelerating Indonesia Collaboration through Global Clinical Capabilities SEOUL, South Korea, Jan. 5,…

Hyundai Motor Group Executive Chair Chung Presents 2026 Vision: Customer-Focused Transformation and AI-Driven Ecosystem Collaboration

Executive Chair Chung emphasizes customer-focused transformation and ecosystem strengthening to navigate evolving…

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

-The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled…

CTA: Despite Tariffs and Economic Headwinds, U.S. Consumer Tech Revenue to Hit $565 Billion in 2026

LAS VEGAS, Jan. 5, 2026 /PRNewswire/ — As tariff pressures and economic uncertainty…

Babies Bliss Establishes a New Standard for Fertility Wellness in Singapore with a Whole-Person, Cycle-Aware Model

Singapore-based Fertility Wellness House positions complementary care as long-term support alongside IVF…